Surprisingly, we found that 62% (69 of 112) of NPC patients showed strong expression of HLA-DP on tumor cells and 13% of cases showed medium expression, while only 25% of cases had almost no expression of HLA-DP on tumor cells (Figure 8B). Here, HLA-DPB1 is linked to neoplasm.